Compound Global Advisors LLC bought a new position in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) during the fourth quarter, Holdings Channel reports. The firm bought 3,084 shares of the company’s stock, valued at approximately $1,138,000. Elevance Health accounts for 4.6% of Compound Global Advisors LLC’s investment portfolio, making the stock its 6th biggest holding.
Other hedge funds also recently made changes to their positions in the company. Raelipskie Partnership bought a new stake in shares of Elevance Health during the 3rd quarter worth $26,000. PSI Advisors LLC bought a new stake in shares of Elevance Health during the 3rd quarter worth $27,000. Eastern Bank bought a new stake in shares of Elevance Health during the 3rd quarter worth $31,000. Crews Bank & Trust bought a new stake in shares of Elevance Health during the 4th quarter worth $34,000. Finally, Dunhill Financial LLC raised its stake in shares of Elevance Health by 57.8% during the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock worth $37,000 after purchasing an additional 26 shares during the period. 89.24% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on the company. Wells Fargo & Company lowered their price objective on Elevance Health from $483.00 to $478.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. TD Cowen lowered their price objective on Elevance Health from $589.00 to $484.00 and set a “buy” rating on the stock in a research note on Monday, October 21st. Argus restated a “hold” rating and issued a $405.40 price objective on shares of Elevance Health in a research note on Wednesday, January 29th. Barclays boosted their price objective on Elevance Health from $501.00 to $512.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, StockNews.com upgraded Elevance Health from a “hold” rating to a “buy” rating in a research note on Tuesday, February 4th. Three equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $517.03.
Elevance Health Stock Up 1.3 %
Shares of NYSE ELV opened at $396.34 on Tuesday. Elevance Health, Inc. has a 12 month low of $362.21 and a 12 month high of $567.26. The company has a current ratio of 1.45, a quick ratio of 1.50 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $91.92 billion, a price-to-earnings ratio of 15.48, a PEG ratio of 1.17 and a beta of 0.83. The business has a 50-day moving average of $385.87 and a 200-day moving average of $452.95.
Elevance Health (NYSE:ELV – Get Free Report) last issued its quarterly earnings data on Thursday, January 23rd. The company reported $3.84 EPS for the quarter, topping the consensus estimate of $3.80 by $0.04. Elevance Health had a return on equity of 18.28% and a net margin of 3.38%. Sell-side analysts expect that Elevance Health, Inc. will post 34.05 earnings per share for the current fiscal year.
Elevance Health Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be issued a dividend of $1.71 per share. This is a positive change from Elevance Health’s previous quarterly dividend of $1.63. The ex-dividend date of this dividend is Monday, March 10th. This represents a $6.84 annualized dividend and a dividend yield of 1.73%. Elevance Health’s payout ratio is presently 26.71%.
About Elevance Health
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Further Reading
- Five stocks we like better than Elevance Health
- How to Choose Top Rated Stocks
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Are Penny Stocks a Good Fit for Your Portfolio?
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Which Wall Street Analysts are the Most Accurate?
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.